<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9878781</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">36703181</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">9878781</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">407</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1186/s12987-023-00407-6</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Population characteristics</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Population characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Value</th></tr></thead><tbody><tr><td align="left">No. of patients</td><td align="left">32</td></tr><tr><td align="left" colspan="2"><italic>Sex</italic></td></tr><tr><td align="left">Female</td><td align="left">21 (65.6%)</td></tr><tr><td align="left">Male</td><td align="left">11 (34.4%)</td></tr><tr><td align="left">Age at the referral</td><td align="left">73.9 ± 6.7 years-old (range 53–86)</td></tr><tr><td align="left" colspan="2"><italic>Neuroradiological parameters</italic></td></tr><tr><td align="left">EI</td><td align="left">0.38 ± 0.04 (range 0.30–0.47)</td></tr><tr><td align="left">CA</td><td align="left">96.3° ± 19.4° (range 63°-130°)</td></tr><tr><td align="left">DESH</td><td align="left">19 (59.4%)</td></tr><tr><td align="left" colspan="2"><italic>Infusion test</italic></td></tr><tr><td align="left">R<sub>out</sub></td><td align="left">11.52 ± 2.45 mmHg/mL/min (range 6.00–16.00)</td></tr><tr><td align="left" colspan="2"><italic>TUG</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">18.34 ± 13.37 (range 10–65)</td></tr><tr><td align="left">Post-test value</td><td align="left">16.67 ± 12.14 (range 9–65)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">7.89 ± 13.56 (range -25.71–34.78)</td></tr><tr><td align="left" colspan="2"><italic>MN</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">11.44 ± 2.53 (range 7.37–17.01)</td></tr><tr><td align="left">Post-test value</td><td align="left">13.38 ± 2.95 (range 8.06–18.95)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">19.92 ± 27.24 (range -25.67–91.06)</td></tr><tr><td align="left" colspan="2"><italic>DMN</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">13.63 ± 3.74 (range 6.77–26.31)</td></tr><tr><td align="left">Post-test value</td><td align="left">16.46 ± 4.01 (range 7.54–30.81)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">25.93 ± 34.40 (range −31.02–139.44)</td></tr><tr><td align="left">VPS implantation</td><td align="left">32/32 (100%)</td></tr><tr><td align="left">Clinical Improvement post-VPS</td><td align="left">26/32 (81%)</td></tr></tbody></table><table-wrap-foot><p>CA, callosal angle; DESH, disproportionately enlarged subarachnoid-space hydrocephalus; DMN, default-mode network; EI, Evans’ index; MN, motor network; R<sub>out</sub>, resistance to outflow; TUG, time up and go; VPS, ventriculoperitoneal shunt</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Population characteristics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Value</th></tr></thead><tbody><tr><td align="left">No. of patients</td><td align="left">32</td></tr><tr><td align="left" colspan="2">Sex</td></tr><tr><td align="left">Female</td><td align="left">21 (65.6%)</td></tr><tr><td align="left">Male</td><td align="left">11 (34.4%)</td></tr><tr><td align="left">Age at the referral</td><td align="left">73.9 ± 6.7 years-old (range 53–86)</td></tr><tr><td align="left" colspan="2">Neuroradiological parameters</td></tr><tr><td align="left">EI</td><td align="left">0.38 ± 0.04 (range 0.30–0.47)</td></tr><tr><td align="left">CA</td><td align="left">96.3° ± 19.4° (range 63°-130°)</td></tr><tr><td align="left">DESH</td><td align="left">19 (59.4%)</td></tr><tr><td align="left" colspan="2">Infusion test</td></tr><tr><td align="left">Rout</td><td align="left">11.52 ± 2.45 mmHg/mL/min (range 6.00–16.00)</td></tr><tr><td align="left" colspan="2">TUG</td></tr><tr><td align="left">Pre-test value</td><td align="left">18.34 ± 13.37 (range 10–65)</td></tr><tr><td align="left">Post-test value</td><td align="left">16.67 ± 12.14 (range 9–65)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">7.89 ± 13.56 (range -25.71–34.78)</td></tr><tr><td align="left" colspan="2">MN</td></tr><tr><td align="left">Pre-test value</td><td align="left">11.44 ± 2.53 (range 7.37–17.01)</td></tr><tr><td align="left">Post-test value</td><td align="left">13.38 ± 2.95 (range 8.06–18.95)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">19.92 ± 27.24 (range -25.67–91.06)</td></tr><tr><td align="left" colspan="2">DMN</td></tr><tr><td align="left">Pre-test value</td><td align="left">13.63 ± 3.74 (range 6.77–26.31)</td></tr><tr><td align="left">Post-test value</td><td align="left">16.46 ± 4.01 (range 7.54–30.81)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">25.93 ± 34.40 (range −31.02–139.44)</td></tr><tr><td align="left">VPS implantation</td><td align="left">32/32 (100%)</td></tr><tr><td align="left">Clinical Improvement post-VPS</td><td align="left">26/32 (81%)</td></tr></tbody></table></div>CA, callosal angle; DESH, disproportionately enlarged subarachnoid-space hydrocephalus; DMN, default-mode network; EI, Evans’ index; MN, motor network; Rout, resistance to outflow; TUG, time up and go; VPS, ventriculoperitoneal shunt</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Cohort stratification</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Cohort stratification</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group 1 (+/+)</th><th align="left">Group 2 (+/−)</th><th align="left">Group 3 (−/ +)</th><th align="left">Group 4 (−/−)</th></tr></thead><tbody><tr><td align="left">No. of patients</td><td align="left">8/32 (25%)</td><td align="left">10/32 (31.25%)</td><td align="left">6/32 (18.75%)</td><td align="left">8/32 (25%)</td></tr><tr><td align="left" colspan="5"><italic>Sex</italic></td></tr><tr><td align="left">Female</td><td align="left">4 (50%)</td><td align="left">9 (90%)</td><td align="left">4 (66.7%)</td><td align="left">4 (50%)</td></tr><tr><td align="left">Male</td><td align="left">4 (50%)</td><td align="left">1 (10%)</td><td align="left">2 (33.3%)</td><td align="left">4 (50%)</td></tr><tr><td align="left">Mean age</td><td align="left">73.6 ± 9.3 (range 53–85)</td><td align="left">71.2 ± 5.7 (range 56–77)</td><td align="left">74.5 ± 3.0 (range 71–79)</td><td align="left">77.0 ± 5.3 (range 67–86)</td></tr><tr><td align="left">Symptoms duration (months)</td><td align="left">18.3 ± 2.7 (range 12–24)</td><td align="left">21.6 ± 7.3 (range 12–30)</td><td align="left">23.2 ± 6.8 (range 12–30)</td><td align="left">37.8 ± 5.4 (range 30–48)</td></tr><tr><td align="left">mFI-11</td><td align="left">4.7 ± 1.1 (range 1–6)</td><td align="left">5.2 ± 1.7 (range 0–7)</td><td align="left">5.3 ± 2.9 (range 2–8)</td><td align="left">7.8 ± 2.1 (range 4–10)</td></tr><tr><td align="left" colspan="5"><italic>Neuroradiological parameters</italic></td></tr><tr><td align="left">EI</td><td align="left">0.39 ± 0.03 (range 0.33–0.45)</td><td align="left">0.38 ± 0.05 (range 0.32–0.47)</td><td align="left">0.36 ± 0.04 (range 0.30–0.43)</td><td align="left">0.37 ± 0.04 (range 0.31–0.41)</td></tr><tr><td align="left">CA</td><td align="left">94.3° ± 24.1° (range 63°–130°)</td><td align="left">95.0° ± 19.4° (range 65°–129°)</td><td align="left">100.7° ± 19.4° (range 79°–130°)</td><td align="left">96.9° ± 12.6° (range 79°–103°)</td></tr><tr><td align="left">DESH</td><td align="left">5 (62.5%)</td><td align="left">8 (80%)</td><td align="left">4 (66.7%)</td><td align="left">2 (25%)</td></tr><tr><td align="left" colspan="5"><italic>Infusion test</italic></td></tr><tr><td align="left">Rout</td><td align="left">13.20 ± 1.00 (range 12.00–15.00)</td><td align="left">13.39 ± 1.29 (range 12.00–16.00)</td><td align="left">9.56 ± 1.79 (range 6.00–11.33)</td><td align="left">8.98 ± 1.43 (range 6.67–11.33)</td></tr><tr><td align="left" colspan="5"><italic>TUG</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">22.56 ± 15.39 (range 13.0–61.0)</td><td align="left">18.15 ± 15.75 (range 10.5–65.0)</td><td align="left">17.33 ± 12.90 (range 10.0–46.0)</td><td align="left">15.13 ± 3.77 (range 10.5–22.0)</td></tr><tr><td align="left">Post-test value</td><td align="left">18.81 ± 13.73 (range 9.5–54.0)</td><td align="left">17.90 ± 15.87 (range 10.0–65.0)</td><td align="left">12.67 ± 7.76 (range 9.0–30.0)</td><td align="left">15.94 ± 4.68 (range 10.5–23.0)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">17.47 ± 5.89 (range 10.71–26.20)</td><td align="left">1.73 ± 6.97 (range −11.76–9.09)</td><td align="left">22.21 ± 8.87 (range 10.00–34.78)</td><td align="left">−4.73 ± 11.35 (range −25.71–8.33)</td></tr><tr><td align="left" colspan="5"><italic>MN</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">12.24 ± 2.92 (range 7.94–17.01)</td><td align="left">9.96 ± 1.65 (range 7.37–13.33)</td><td align="left">13.04 ± 2.27 (range 8.66–16.09)</td><td align="left">11.92 ± 2.10 (range 7.45–13.96)</td></tr><tr><td align="left">Post-test value</td><td align="left">15.38 ± 1.87 (range 12.18–18.95)</td><td align="left">12.97 ± 2.96 (range 8.06–17.38)</td><td align="left">14.95 ± 2.40 (range 10.38–17.54)</td><td align="left">10.73 ± 1.70 (range 8.06–13.56)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">30.73 ± 26.46 (range 7.81–91.06)</td><td align="left">30.16 ± 21.14 (range 2.94–66.63)</td><td align="left">15.28 ± 9.21 (range 4.40–31.99)</td><td align="left">−0.20 ± 31.25 (range −25.65–59.19)</td></tr><tr><td align="left" colspan="5"><italic>DMN</italic></td></tr><tr><td align="left">Pre-test value</td><td align="left">12.98 ± 3.97 (range 6.77–18.33)</td><td align="left">14.24 ± 4.42 (range 9.78–26.31)</td><td align="left">12.57 ± 2.29 (range 10.04–16.06)</td><td align="left">14.30 ± 3.09 (range 10.40–18.56)</td></tr><tr><td align="left">Post-test value</td><td align="left">17.05 ± 2.67 (range 12.56–21.59)</td><td align="left">18.31 ± 4.74 (range 14.02–30.81)</td><td align="left">16.60 ± 1.59 (range 14.47–19.00)</td><td align="left">13.44 ± 3.67 (range 7.54–18.59)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">41.06 ± 39.92 (range 7.26–139.44)</td><td align="left">32.56 ± 26.71 (range 2.57–86.07)</td><td align="left">34.12 ± 11.34 (range 18.31–44.47)</td><td align="left">−3.63 ± 30.71 (range -31.02–49.29)</td></tr><tr><td align="left" colspan="5"><italic>Surgery</italic></td></tr><tr><td align="left">VPS implantation</td><td align="left">8/8 (100%)</td><td align="left">10/10 (100%)</td><td align="left">6/6 (100%)</td><td align="left">8/8 (100%)</td></tr><tr><td align="left">Clinical Improvement</td><td align="left">8/8 (100%)</td><td align="left">10/10 (100%)</td><td align="left">6/6 (100%)</td><td align="left">2/8 (25%)</td></tr></tbody></table><table-wrap-foot><p>CA, callosal angle; DESH, disproportionately enlarged subarachnoid-space hydrocephalus; DMN, default-mode network; EI, Evans’ index; mFI-11, modified-frailty index-11; MN, motor network; R<sub>out</sub>, resistance to outflow; TUG, time up and go; VPS, ventriculoperitoneal shunt. No statistical significant difference between neuroradiological parameters before and after the test was recorded. For this reason, in this table, we report only basal values</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cohort stratification</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group 1 (+/+)</th><th align="left">Group 2 (+/−)</th><th align="left">Group 3 (−/ +)</th><th align="left">Group 4 (−/−)</th></tr></thead><tbody><tr><td align="left">No. of patients</td><td align="left">8/32 (25%)</td><td align="left">10/32 (31.25%)</td><td align="left">6/32 (18.75%)</td><td align="left">8/32 (25%)</td></tr><tr><td align="left" colspan="5">Sex</td></tr><tr><td align="left">Female</td><td align="left">4 (50%)</td><td align="left">9 (90%)</td><td align="left">4 (66.7%)</td><td align="left">4 (50%)</td></tr><tr><td align="left">Male</td><td align="left">4 (50%)</td><td align="left">1 (10%)</td><td align="left">2 (33.3%)</td><td align="left">4 (50%)</td></tr><tr><td align="left">Mean age</td><td align="left">73.6 ± 9.3 (range 53–85)</td><td align="left">71.2 ± 5.7 (range 56–77)</td><td align="left">74.5 ± 3.0 (range 71–79)</td><td align="left">77.0 ± 5.3 (range 67–86)</td></tr><tr><td align="left">Symptoms duration (months)</td><td align="left">18.3 ± 2.7 (range 12–24)</td><td align="left">21.6 ± 7.3 (range 12–30)</td><td align="left">23.2 ± 6.8 (range 12–30)</td><td align="left">37.8 ± 5.4 (range 30–48)</td></tr><tr><td align="left">mFI-11</td><td align="left">4.7 ± 1.1 (range 1–6)</td><td align="left">5.2 ± 1.7 (range 0–7)</td><td align="left">5.3 ± 2.9 (range 2–8)</td><td align="left">7.8 ± 2.1 (range 4–10)</td></tr><tr><td align="left" colspan="5">Neuroradiological parameters</td></tr><tr><td align="left">EI</td><td align="left">0.39 ± 0.03 (range 0.33–0.45)</td><td align="left">0.38 ± 0.05 (range 0.32–0.47)</td><td align="left">0.36 ± 0.04 (range 0.30–0.43)</td><td align="left">0.37 ± 0.04 (range 0.31–0.41)</td></tr><tr><td align="left">CA</td><td align="left">94.3° ± 24.1° (range 63°–130°)</td><td align="left">95.0° ± 19.4° (range 65°–129°)</td><td align="left">100.7° ± 19.4° (range 79°–130°)</td><td align="left">96.9° ± 12.6° (range 79°–103°)</td></tr><tr><td align="left">DESH</td><td align="left">5 (62.5%)</td><td align="left">8 (80%)</td><td align="left">4 (66.7%)</td><td align="left">2 (25%)</td></tr><tr><td align="left" colspan="5">Infusion test</td></tr><tr><td align="left">Rout</td><td align="left">13.20 ± 1.00 (range 12.00–15.00)</td><td align="left">13.39 ± 1.29 (range 12.00–16.00)</td><td align="left">9.56 ± 1.79 (range 6.00–11.33)</td><td align="left">8.98 ± 1.43 (range 6.67–11.33)</td></tr><tr><td align="left" colspan="5">TUG</td></tr><tr><td align="left">Pre-test value</td><td align="left">22.56 ± 15.39 (range 13.0–61.0)</td><td align="left">18.15 ± 15.75 (range 10.5–65.0)</td><td align="left">17.33 ± 12.90 (range 10.0–46.0)</td><td align="left">15.13 ± 3.77 (range 10.5–22.0)</td></tr><tr><td align="left">Post-test value</td><td align="left">18.81 ± 13.73 (range 9.5–54.0)</td><td align="left">17.90 ± 15.87 (range 10.0–65.0)</td><td align="left">12.67 ± 7.76 (range 9.0–30.0)</td><td align="left">15.94 ± 4.68 (range 10.5–23.0)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">17.47 ± 5.89 (range 10.71–26.20)</td><td align="left">1.73 ± 6.97 (range −11.76–9.09)</td><td align="left">22.21 ± 8.87 (range 10.00–34.78)</td><td align="left">−4.73 ± 11.35 (range −25.71–8.33)</td></tr><tr><td align="left" colspan="5">MN</td></tr><tr><td align="left">Pre-test value</td><td align="left">12.24 ± 2.92 (range 7.94–17.01)</td><td align="left">9.96 ± 1.65 (range 7.37–13.33)</td><td align="left">13.04 ± 2.27 (range 8.66–16.09)</td><td align="left">11.92 ± 2.10 (range 7.45–13.96)</td></tr><tr><td align="left">Post-test value</td><td align="left">15.38 ± 1.87 (range 12.18–18.95)</td><td align="left">12.97 ± 2.96 (range 8.06–17.38)</td><td align="left">14.95 ± 2.40 (range 10.38–17.54)</td><td align="left">10.73 ± 1.70 (range 8.06–13.56)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">30.73 ± 26.46 (range 7.81–91.06)</td><td align="left">30.16 ± 21.14 (range 2.94–66.63)</td><td align="left">15.28 ± 9.21 (range 4.40–31.99)</td><td align="left">−0.20 ± 31.25 (range −25.65–59.19)</td></tr><tr><td align="left" colspan="5">DMN</td></tr><tr><td align="left">Pre-test value</td><td align="left">12.98 ± 3.97 (range 6.77–18.33)</td><td align="left">14.24 ± 4.42 (range 9.78–26.31)</td><td align="left">12.57 ± 2.29 (range 10.04–16.06)</td><td align="left">14.30 ± 3.09 (range 10.40–18.56)</td></tr><tr><td align="left">Post-test value</td><td align="left">17.05 ± 2.67 (range 12.56–21.59)</td><td align="left">18.31 ± 4.74 (range 14.02–30.81)</td><td align="left">16.60 ± 1.59 (range 14.47–19.00)</td><td align="left">13.44 ± 3.67 (range 7.54–18.59)</td></tr><tr><td align="left">Improvement (%)</td><td align="left">41.06 ± 39.92 (range 7.26–139.44)</td><td align="left">32.56 ± 26.71 (range 2.57–86.07)</td><td align="left">34.12 ± 11.34 (range 18.31–44.47)</td><td align="left">−3.63 ± 30.71 (range -31.02–49.29)</td></tr><tr><td align="left" colspan="5">Surgery</td></tr><tr><td align="left">VPS implantation</td><td align="left">8/8 (100%)</td><td align="left">10/10 (100%)</td><td align="left">6/6 (100%)</td><td align="left">8/8 (100%)</td></tr><tr><td align="left">Clinical Improvement</td><td align="left">8/8 (100%)</td><td align="left">10/10 (100%)</td><td align="left">6/6 (100%)</td><td align="left">2/8 (25%)</td></tr></tbody></table></div>CA, callosal angle; DESH, disproportionately enlarged subarachnoid-space hydrocephalus; DMN, default-mode network; EI, Evans’ index; mFI-11, modified-frailty index-11; MN, motor network; Rout, resistance to outflow; TUG, time up and go; VPS, ventriculoperitoneal shunt. No statistical significant difference between neuroradiological parameters before and after the test was recorded. For this reason, in this table, we report only basal values</transformed-table></extracted-table></extracted-tables-set>